A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2004
12/01/2004	EP1196383B1 Process for preparing amlodipine benzenesulphonate
12/01/2004	EP1183040B1 Therapeutic use of an inhibitor of a hedgehog signalling pathway
12/01/2004	EP1176975A4 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
12/01/2004	EP1175408B1 Pyrimidinone compounds
12/01/2004	EP1121449A4 Delivery system for porcine somatotropin
12/01/2004	EP1104407B1 Compounds as selective agonists at alpha 2b or 2b/2c adrenergic receptors
12/01/2004	EP1082422B1 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation
12/01/2004	EP1075264B1 New drug combinations of reboxetine and pindolol
12/01/2004	EP1061961B1 Apparatuses and processes for whole-body hyperthermia
12/01/2004	EP1056462A4 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	EP0930076B1 Pharmaceutical compositions comprising CS-866 and insulin resistance improving agents and their use for the treatment of arteriosclerosis and xanthoma
12/01/2004	EP0917571B1 Agouti-related gene
12/01/2004	EP0886637B1 Inhibitors of microsomal triglyceride transfer protein and method
12/01/2004	CN1551880A Crystalline forms of valacyclovir hydrochloride
12/01/2004	CN1551878A 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
12/01/2004	CN1551877A Piperidine derivatives useful as CCR5 antagonists
12/01/2004	CN1551872A Biologically active methylene blue derivatives
12/01/2004	CN1551869A Novel compound
12/01/2004	CN1551789A Single dose aromatase inhibitor for treating infertility
12/01/2004	CN1551785A Sustained release of microcrystalline peptide suspensions
12/01/2004	CN1551784A Prostaglandin compositions and methods of treatment for male erectile dysfunction
12/01/2004	CN1551781A One dose vaccination with mycoplasma hyopneumoniae
12/01/2004	CN1551779A Osteogenis oligopeptide as blood-formation stimulation articles
12/01/2004	CN1551769A Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
12/01/2004	CN1551763A Novel treatment method
12/01/2004	CN1551760A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
12/01/2004	CN1551728A Production of transduced hematopoietic progenitor cells
12/01/2004	CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004	CN1550233A Skin patch and method for administering testosterone
12/01/2004	CN1177863C Attenuated microorganisms for treatment of infection
12/01/2004	CN1177861C Macrocylic peptides active against the hepatitis V virus
12/01/2004	CN1177857C Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives
12/01/2004	CN1177855C Carbohydrate derivatives
12/01/2004	CN1177847C Oxazolidines compounds as 5-HT2A-antagonists
12/01/2004	CN1177844C Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof
12/01/2004	CN1177834C Dihydroxyhexanoic acid derivatives
12/01/2004	CN1177833C Substd. quinazoline derivatives
12/01/2004	CN1177832C Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
12/01/2004	CN1177831C New benzimidazolone-benzoxazolone-, or benzothiazoloe derivatives as ion channel modulating agents
12/01/2004	CN1177830C Benzoheterocycles and their use as MEK inhibitors
12/01/2004	CN1177829C Substituted sulphonyl cyanamides, method for producing same and their use as medicament
12/01/2004	CN1177821C Matrix metalloprotease inhibitors
12/01/2004	CN1177615C Arteriovenous and venous graft treatment methods and compsns.
12/01/2004	CN1177598C Medicine for eliminating side effect of radiotherapy and chemotherapy to treat malignant tumor and its prepn
12/01/2004	CN1177596C Ginkgo biloba leaf extracts with reduced 4'-0-methypyridoxine and biflavone content
12/01/2004	CN1177595C Use of composition for increasing insulin activity
11/2004
11/30/2004	US6825355 For therapy of immunologic disorders such as transplant rejection, rheumatoid arthritis. multiple sclerosis, inflammatory bowel disease, lupus, graft vs. host disease
11/30/2004	US6825349 Purine derivatives for treatment of gastrointestinal disorders, immunological disorders, neurological disorders
11/30/2004	US6825331 Aminooxy functionalized oligomers, oligomer arrays and methods of using them
11/30/2004	US6825324 Antibodies to receptor protein tyrosine kinases
11/30/2004	US6825318 Vaccine for obesity therapy; hybrid polypeptides
11/30/2004	US6825229 Administering protein kinase c activators such as macrocyclic lactones (i.e. bryostatin class and neristatin class)
11/30/2004	US6825226 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
11/30/2004	US6825224 Prodrugs of carbamate inhibitors of IMPDH
11/30/2004	US6825223 Anilide compounds and pharmaceutical compositions comprising them
11/30/2004	US6825222 Modulators of peroxisome proliferator activated receptors
11/30/2004	US6825221 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
11/30/2004	US6825220 3-Substituted oxindole β 3 agonists
11/30/2004	US6825219 Substituted benzimidazole compounds
11/30/2004	US6825217 Heterocyclic amines such as 4-(3'-thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
11/30/2004	US6825213 β3-adrenoreceptor agonists, agonist compositions and methods of using
11/30/2004	US6825210 5,10-dihydrobenzo(b)(1,8)naphthyridine compounds, n-oxides; 3,7-dichloro-5-isopropoxymethyl-5-trifluoromethyl-5,10 -dihydrobenzo(b)(1,8)naphthyridine for example; combination therapy
11/30/2004	US6825204 N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/30/2004	US6825202 Central nervous system disorders; psychological disorders
11/30/2004	US6825200 Substituted dipeptides having nos inhibiting activity
11/30/2004	US6825198 5-HT receptor ligands and uses thereof
11/30/2004	US6825197 Cyclic GMP-specific phosphodiesterase inhibitors
11/30/2004	US6825194 Hexacyclic compounds
11/30/2004	US6825190 Protein kinase inhibitors and uses thereof
11/30/2004	US6825186 Method and compositions for treating atheroma, tumors and other neoplastic tissue
11/30/2004	US6825185 Improving the cardiovascular profile of a cox-2 selective inhibitor by administering with 3-hydroxy-3- methylglutaryl coenzyme a, an antiplatelet agent, a thrombin inhibitor or a thromboxane inhibitor
11/30/2004	US6825180 Cytokine intracellular signaling inhibitors; antiinflammatory agents
11/30/2004	US6825015 Process for the obtaining of HMG-COA reductase inhibitors of high purity
11/30/2004	US6824991 Human bad polypeptides, encoding nucleic acids and methods of use
11/30/2004	CA2251795C Novel n-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands
11/27/2004	CA2464379A1 Use of anti-glaucoma drugs to treat visual defects associated with the use of a gabaergic agent
11/25/2004	WO2004101593A1 5'-modified nucleoside derivative and medicinal use thereof
11/25/2004	WO2004101551A1 Crystal of benzimidazole derivative and process for producing the same
11/25/2004	WO2004101529A1 Nitrogenous heterocyclic compound and medical use thereof
11/25/2004	WO2004101526A1 Polymorphous crystal of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-qunolinecarboxamide and method for preparation thereof
11/25/2004	WO2004101514A1 Cyanofluoropyrrolidine derivative
11/25/2004	WO2004101483A1 Novel trisubstituted benzene derivative, process for producing the same and medical drug composition containing the derivative
11/25/2004	WO2004100989A1 Preventives/remedies for snore or respiratory disturbances during sleep
11/25/2004	WO2004100972A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	WO2004100962A1 Melanogenesis inhibitory substance
11/25/2004	WO2004100961A1 Sulfate group transferase inhibitor
11/25/2004	WO2004089356A3 Targeted bone marrow protection agents
11/25/2004	WO2004062606A3 Method of achieving accelerated fat loss by administration of a fat loss accelerating agent to a dieting mammal
11/25/2004	US20040236147 Integrin antagonist; antiinflammatory agents; antiarthritic agents; inflammatory bowel disease; lupus; multiple sclerosis; asthma; psoriasis;antidiabetic agents; cardiovascular disorders
11/25/2004	US20040236116 Novel bicyclic and tricyclic cannabinoids
11/25/2004	US20040236112 Hepatitis C Virus (HCV); antiproliferative agents; replication-defective
11/25/2004	US20040236111 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
11/25/2004	US20040236109 Tetrahydroquinoline derivatives
11/25/2004	US20040236101 Heteroindanes a new class of potent cannabimimetic ligands
11/25/2004	US20040236098 Tocopheryl retinyl succinate, tocopheryl cholecalciferyl succinate or tocopheryl ascorbyl succinate; sustained releasing active agents or vitamin by hydrolyzing with esterase contained in the skin; dermatology, cosmetics
11/25/2004	US20040236073 A polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor
11/25/2004	US20040235950 Administering, topically or systemically, an inhibitor of the matrix degrading enzymes and a cytokine inhibitor that alleviates inflammation and also alleviate neutrophil infiltration
11/25/2004	US20040235933 Administering aromatic or heteroaromatic substituted indolealkanoic acid derivataives for the treatment of chronic complications arising from diabetes mellitus e.g. diabetic cataracts, retinopathy, nephropathy and neuropathy

1 ... 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 ... 1564